Personalis, Inc. Restricted Cash and Investments, Noncurrent
Personalis, Inc. (PSNL) had Restricted Cash and Investments, Noncurrent of $1.79 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndInvestmentsNoncurrent · last filed 2026-08-04
- 2026-06-30: Restricted Cash and Investments, Noncurrent $1.79M.
- 2026-03-31: Restricted Cash and Investments, Noncurrent $1.79M.
- 2025-12-31: Restricted Cash and Investments, Noncurrent $1.79M.
- 2025-09-30: Restricted Cash and Investments, Noncurrent $1.79M.
| Period end | Restricted Cash and Investments, Noncurrent |
|---|---|
| 2026-06-30 | $1.79M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.79M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.79M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.79M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $1.79M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $1.79M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $1.79M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.79M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $1.79M 10-Q · filed 2025-08-05 |
| 2024-03-31 | $1.79M 10-Q · filed 2025-05-06 |
| 2023-12-31 | $1.79M 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.79M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $1.79M 10-Q · filed 2024-08-07 |
| 2023-03-31 | $1.79M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $1.79M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.79M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $1.79M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $1.79M 10-Q · filed 2023-05-03 |
| 2021-12-31 | $1.79M 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.79M 10-Q · filed 2022-11-02 |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |